Literature DB >> 35738588

NGS-identified miRNAs in Canine Mammary Gland Tumors Show Unexpected Expression Alterations in qPCR Analysis.

Hui-Wen Chen1, Yu-Chang Lai2, Md Mahfuzur Rahman2, Al Asmaul Husna2, Md Nazmul Hasan1, Hitoshi Hatai1,2, Noriaki Miyoshi1,2, Osamu Yamato1,2, Naoki Miura3,2.   

Abstract

BACKGROUND/AIM: Canine mammary gland tumors (MGTs), as a potential model of human breast cancer, have a well-defined histological classification system. MicroRNA (miRNA) expression is a key part of the molecular signatures of both MGTs and human breast cancer, although the signatures alone do not yet provide a sufficient basis for definitive diagnosis. In this study, we investigated the association between miRNA expression patterns and histological classification.
MATERIALS AND METHODS: Mammary gland tissue was collected from healthy dogs (n=7) and dog patients (n=80). Further samples (n=5) were obtained from established MGT cell lines. We targeted miRNAs differentially expressed in metastatic tumor tissue versus non-metastatic and normal tissue. A subset of samples was analyzed using small RNA next generation sequencing (NGS) with subsequent qPCR.
RESULTS: Six differentially expressed miRNAs were selected from the NGS analysis and submitted for large-scale qPCR. The large-scale qPCR analysis revealed greater alternations in miRNA expression. Large-scale analysis, based on 79 samples, revealed a hierarchical clustering based on selected miRNAs that did not strikingly match the histopathological subtype classification.
CONCLUSION: We successfully investigated the large-scale miRNA expression pattern in canine MGT and provided the whole miRNA expression. The selected miRNA demonstrated that there is no straightforward mapping between molecular signatures and histological classification of canine MGTs at the miRNA level.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Canine MGT; NGS; dog; microRNA; transcriptome

Mesh:

Substances:

Year:  2022        PMID: 35738588      PMCID: PMC9301395          DOI: 10.21873/invivo.12873

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.406


  23 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  The molecular pathology of breast cancer progression.

Authors:  Alessandro Bombonati; Dennis C Sgroi
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

3.  MicroRNA expression in canine mammary cancer.

Authors:  R Michelle Boggs; Zachary M Wright; Mark J Stickney; Weston W Porter; Keith E Murphy
Journal:  Mamm Genome       Date:  2008-07-30       Impact factor: 2.957

4.  Challenges in projecting clustering results across gene expression-profiling datasets.

Authors:  Lara Lusa; Lisa M McShane; James F Reid; Loris De Cecco; Federico Ambrogi; Elia Biganzoli; Manuela Gariboldi; Marco A Pierotti
Journal:  J Natl Cancer Inst       Date:  2007-11-13       Impact factor: 13.506

5.  Breast cancer molecular profiling with single sample predictors: a retrospective analysis.

Authors:  Britta Weigelt; Alan Mackay; Roger A'hern; Rachael Natrajan; David S P Tan; Mitch Dowsett; Alan Ashworth; Jorge S Reis-Filho
Journal:  Lancet Oncol       Date:  2010-02-22       Impact factor: 41.316

6.  miRBase: integrating microRNA annotation and deep-sequencing data.

Authors:  Ana Kozomara; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

7.  MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.

Authors:  Malgorzata Bulkowska; Agata Rybicka; Kerem Mert Senses; Katarzyna Ulewicz; Katarzyna Witt; Joanna Szymanska; Bartlomiej Taciak; Robert Klopfleisch; Eva Hellmén; Izabella Dolka; Ali O Gure; Joanna Mucha; Mariusz Mikow; Slawomir Gizinski; Magdalena Krol
Journal:  BMC Cancer       Date:  2017-11-07       Impact factor: 4.430

8.  miRBase: from microRNA sequences to function.

Authors:  Ana Kozomara; Maria Birgaoanu; Sam Griffiths-Jones
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

9.  Ensembl 2020.

Authors:  Andrew D Yates; Premanand Achuthan; Wasiu Akanni; James Allen; Jamie Allen; Jorge Alvarez-Jarreta; M Ridwan Amode; Irina M Armean; Andrey G Azov; Ruth Bennett; Jyothish Bhai; Konstantinos Billis; Sanjay Boddu; José Carlos Marugán; Carla Cummins; Claire Davidson; Kamalkumar Dodiya; Reham Fatima; Astrid Gall; Carlos Garcia Giron; Laurent Gil; Tiago Grego; Leanne Haggerty; Erin Haskell; Thibaut Hourlier; Osagie G Izuogu; Sophie H Janacek; Thomas Juettemann; Mike Kay; Ilias Lavidas; Tuan Le; Diana Lemos; Jose Gonzalez Martinez; Thomas Maurel; Mark McDowall; Aoife McMahon; Shamika Mohanan; Benjamin Moore; Michael Nuhn; Denye N Oheh; Anne Parker; Andrew Parton; Mateus Patricio; Manoj Pandian Sakthivel; Ahamed Imran Abdul Salam; Bianca M Schmitt; Helen Schuilenburg; Dan Sheppard; Mira Sycheva; Marek Szuba; Kieron Taylor; Anja Thormann; Glen Threadgold; Alessandro Vullo; Brandon Walts; Andrea Winterbottom; Amonida Zadissa; Marc Chakiachvili; Bethany Flint; Adam Frankish; Sarah E Hunt; Garth IIsley; Myrto Kostadima; Nick Langridge; Jane E Loveland; Fergal J Martin; Joannella Morales; Jonathan M Mudge; Matthieu Muffato; Emily Perry; Magali Ruffier; Stephen J Trevanion; Fiona Cunningham; Kevin L Howe; Daniel R Zerbino; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

10.  Malignancy Associated MicroRNA Expression Changes in Canine Mammary Cancer of Different Malignancies.

Authors:  Marie-Charlotte von Deetzen; Bernd T Schmeck; Achim D Gruber; Robert Klopfleisch
Journal:  ISRN Vet Sci       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.